Delaware
|
|
72-3241964
|
(State
or other jurisdiction of
incorporation
or organization)
|
|
(I.R.S.
Employer
Identification
No.)
|
Financial
Statements:
|
|
|
|
|
|
Condensed
Balance Sheets
|
F-1
|
|
|
|
|
Condensed
Statements of Operations
|
F-2
|
|
|
|
|
Condensed
Statements of Stockholders’ Equity
|
F-3
|
|
|
|
|
Condensed
Statements of Cash Flows
|
F-4
|
|
|
|
|
F-5-
F-9
|
June 30, 2008
|
December 31, 2007
|
||||||
(unaudited)
|
|||||||
ASSETS
|
|||||||
Current
assets
|
|||||||
Cash
|
$
|
45,626
|
$
|
71,274
|
|||
Prepaid
expenses
|
64,904
|
54,075
|
|||||
Deferred
acquisition costs
|
107,363
|
||||||
217,893
|
125,349
|
||||||
Other
assets
|
|||||||
Cash
and cash equivalents held in Trust Account
|
37,498,748
|
37,720,479
|
|||||
Deferred
tax asset
|
172,169
|
32,210
|
|||||
37,670,917
|
37,752,689
|
||||||
TOTAL
ASSETS
|
$
|
37,888,810
|
$
|
37,878,038
|
|||
|
|||||||
LIABILITIES
AND STOCKHOLDERS' EQUITY
|
|||||||
|
|||||||
Current
liabilities, accounts
payable and accrued expenses
|
$
|
310,383
|
$
|
174,344
|
|||
|
|||||||
Long-term
liabilities, deferred
underwriters' fee
|
1,514,760
|
1,514,760
|
|||||
Common
stock, subject to possible redemption, 1,419,614 shares, at redemption
value
|
11,232,133
|
11,232,133
|
|||||
|
|||||||
Stockholders'
equity
|
|||||||
Preferred
stock, $.0001 par value; 1,000,000 shares authorized; none
issued
|
-
|
-
|
|||||
Common
stock, $.0001 par value, authorized 20,000,000 shares; 5,917,031
shares
issued and outstanding, (including 1,419,614 shares subject to possible
redemption)
|
602
|
602
|
|||||
Additional
paid-in capital
|
24,873,742
|
24,873,742
|
|||||
Earnings
(deficit) accumulated during the development stage
|
(42,810
|
)
|
82,457
|
||||
Total
stockholders' equity
|
24,831,534
|
24,956,801
|
|||||
TOTAL
LIABILITIES AND STOCKHOLDERS' EQUITY
|
$
|
37,888,810
|
$
|
37,878,038
|
|
For
the three
months
ended
June
30, 2008
|
For
the six
months
ended
June
30, 2008
|
May
22, 2007
(inception)
to
June
30, 2008
|
May
22, 2007
(inception)
to
June
30, 2007
|
|||||||||
|
|
|
|
|
|||||||||
|
|
|
|
|
|||||||||
Interest
income
|
$
|
113,723
|
$
|
280,209
|
$
|
548,437
|
$
|
40
|
|||||
|
|||||||||||||
Operating
costs
|
73,298
|
430,144
|
544,410
|
600
|
|||||||||
Provision
(benefit) for income taxes
|
(87,666
|
)
|
(24,668
|
)
|
46,837
|
-
|
|||||||
|
|||||||||||||
Net
(loss) income
|
$
|
128,091
|
$
|
(125,267
|
)
|
$
|
(42,810
|
)
|
$
|
(560
|
)
|
||
|
|||||||||||||
Maximum
number of shares subject to possible redemption:
|
|||||||||||||
Weighted
average number of common shares, Basic and diluted
|
1,419,614
|
1,419,614
|
1,419,614
|
-
|
|||||||||
|
|||||||||||||
Net
income per common share,
for shares subject to redemption
|
-
|
-
|
-
|
-
|
|||||||||
|
|||||||||||||
Approximate
weighted average number of common shares outstanding (not subject
to
possible redemption)
|
|||||||||||||
Basic
|
4,497,417
|
4,497,417
|
3,317,902
|
1,293,750
|
|||||||||
Diluted
|
5,563,568
|
4,497,417
|
3,317,902
|
1,293,750
|
|||||||||
|
|||||||||||||
Net
income per common share not subject to possible
redemption,
|
|||||||||||||
Basic
|
$
|
0.028
|
$
|
(0.028
|
)
|
$
|
(0.013
|
)
|
$
|
-
|
|||
Diluted
|
$
|
0.023
|
$
|
(0.028
|
)
|
$
|
(0.013
|
)
|
$
|
-
|
Deficit
|
||||||||||||||||
|
Accumulated
|
|
||||||||||||||
Additional
|
During
|
Total
|
||||||||||||||
Common Stock
|
Paid-in
|
Development
|
Stockholders'
|
|||||||||||||
Shares
|
Amount
|
Capital
|
Stage
|
Equity
|
||||||||||||
Common shares
issued to existing shareholders
|
1,183,406
|
$
|
129
|
$
|
24,871
|
$
|
-
|
$
|
25,000
|
|||||||
Proceeds
from issuance of warrants
|
1,250,000
|
1,250,000
|
||||||||||||||
Sale
of 4,733,625 units on October 11, 2007 at a price of $8 per unit,
net of
underwriters' discount and offering costs (including 1,419,614 shares
subject to possible redemption)
|
4,733,625
|
473
|
34,830,904
|
34,831,377
|
||||||||||||
Common
stock, subject to possible redemption, 1,419,614 shares
|
(11,232,133
|
)
|
(11,232,133
|
)
|
||||||||||||
Proceeds
from issuance of options
|
100
|
100
|
||||||||||||||
Net
income for period
|
|
|
|
82,457
|
82,457
|
|||||||||||
Balances,
December 31, 2007
|
5,917,031
|
602
|
24,873,742
|
82,457
|
24,956,801
|
|||||||||||
Net
loss for the period
|
|
|
|
(125,267
|
)
|
(125,267
|
)
|
|||||||||
Balances,
June 30, 2008
|
5,917,031
|
$
|
602
|
$
|
24,873,742
|
$
|
(42,810
|
)
|
$
|
24,831,534
|
For the six
months ended
June 30, 2008
|
May 22, 2007
(inception) to
June 30, 2008
|
May 22, 2007
(inception) to
June 30, 2007
|
||||||||
Cash
flows from operating activities
|
||||||||||
Net
loss
|
$
|
(125,267
|
)
|
$
|
(42,810
|
)
|
$
|
(560
|
)
|
|
Adjustments
to reconcile net loss to cash used in operating activities
|
||||||||||
Deferred
income tax (benefit)
|
(139,959
|
)
|
(172,169
|
)
|
||||||
Increase
(decrease) in cash attributable to changes in operating assets and
liabilities
|
||||||||||
Prepaid
expenses
|
(10,829
|
)
|
(64,904
|
)
|
||||||
Deferred
acquisition costs
|
(107,363
|
)
|
(107,363
|
)
|
||||||
Accounts
payable and accrued expenses
|
136,039
|
310,383
|
560
|
|||||||
Net
cash used in operating activities
|
(247,379
|
)
|
(76,863
|
)
|
-
|
|||||
Cash
provided by (used) in investing activities,
change in restricted
cash and cash equivalents held in trust account
|
221,731
|
(37,498,748
|
)
|
-
|
||||||
Cash
flows from investing activities
|
||||||||||
Proceeds
from notes payable, stockholders
|
100,000
|
100,000
|
||||||||
Repayment
of notes payable, stockholders
|
(100,000
|
)
|
||||||||
Proceeds
from issuance of common stock
|
25,000
|
25,000
|
||||||||
Proceeds
from issuance of warrants
|
1,250,000
|
|||||||||
Gross
proceeds from public offering
|
37,869,000
|
|||||||||
Payments
for underwriters’ discount and offering cost
|
(1,522,863
|
)
|
(66,264
|
)
|
||||||
Proceeds
from issuance of option
|
100
|
|||||||||
Net
cash provided by financing activities
|
-
|
37,621,237
|
58,736
|
|||||||
Net
increase (decrease) in cash
|
(25,648
|
)
|
45,626
|
58,736
|
||||||
Cash,
beginning
of period
|
71,274
|
-
|
-
|
|||||||
Cash,
ending
of period
|
$
|
45,626
|
$
|
45,626
|
$
|
58,736
|
||||
Supplemental
schedule of non-cash financing activities:
|
||||||||||
Accrual
of deferred underwriter’s fee and offering cost
|
$
|
-
|
$
|
1,514,760
|
$
|
62,500
|
||||
Supplemental
disclosure for taxes and interest paid:
|
||||||||||
Taxes
paid
|
$
|
266,489
|
$
|
266,489
|
$
|
-
|
31.1
|
Section
302 Certification of Principal Executive Officer
|
|
|
31.2
|
Section
302 Certification of Principal Financial Officer
|
|
|
32.1
|
Section
906 Certification of Principal Executive Officer
|
|
|
32.2
|
Section
906 Certification of Principal Financial
Officer
|
|
FMG
ACQUISITION CORP.
|
|
|
Dated:
August 14, 2008
|
|
|
|
|
Gordon
G. Pratt
|
|
President
and Chief Executive Officer
|
|
(Principal
executive officer)
|
|
|
|
/s/
Larry G. Swets, Jr.
|
|
Larry
G. Swets, Jr.
|
|
|
|
(Principal
financial and accounting officer)
|